Retrospective Study of Outcomes and Hospitalization Rates of Patients in Italy with a Confirmed Diagnosis of Early COVID-19 and Treated at Home Within 3 Days or After 3 Days of Symptom Onset with Prescribed and Non-Prescribed Treatments Between November 2020 and August 2021

30 December 2021 : Clinical Research

Serafino Fazio^1ABDEF, Paolo Bellavite^2AE*, Elisabetta Zanolin^3CD, Peter A. McCullough

^4DE, Sergio Pandolfi^5AD, Flora Affuso^6ABF

DOI: 10.12659/MSM.935379

Med Sci Monit 2021; 27:e935379

Background Material and Methods Results Discussion Conclusions References

Related articles Order reprints Share article Share by email

View HTML version

Table 1 General characteristics of the study groups.

Variable*	Group 1 (n=85)	Group 2 (n=73)	p value**
Age, yrs.	47.14±13.45	45.29±11.54	0.359
Females, n (%)	48 (56.5)	36 (49.3)	0.369
Weight, Kg	75.0 [44.0; 140.0]	76.0 [50.0; 135.0]	0.676
BMI, (Kg/m)	25.16 [15.5; 56.2]	24.38 [20.5; 52.7]	0.404
Saturation at 1 visit, %	97.0 [94.0; 99.0]	97.0 [94.0; 99.0]	0.503
Hypertension, n (%)	24 (28.23)	15 (20.55)	0.263
Diabetes Mellitus, n (%)	8 (9.41)	10 (13.69)	0.397
IHD	6 (7.05)	4 (5.47)	0.684
Temperature >37°C, n (%)	63 (74.1)	55 (75.3)	0.859
Temperature, mean (°C)	37.42±0.61	37.29±0.43
Headache, n (%)	58 (68.23)	50 (68.49)	0.972
Osteomuscular pain, n (%)	59 (69.41)	51 (69.86)	0.950
Rhinitis, n (%)	62 (72.94)	54 (73.97)	0.883
Sore throat, n (%)	60 (70.58)	51 (69.86)	0.921
Cough, n (%)	63 (74.11)	54 (73.97)	0.983
Taste and/or smell alterations, n (%)	42 (49.41)	36 (49.31)	0.941
Bellyache, diarrhea, n (%)	32 (37.64)	26 (35.61)	0.791
Pleural pain, n (%)	18 (21.17)	17 (23.28)	0.750
^* Continuous variables are summarized as median [minimum; maximum] or mean±standard deviation, as appropriate; discrete variables are summarized as absolute number (percentage). BMI – body mass index; IHD – ischemic heart disease. ^** T-test for continuous variables and χ or Fisher exact test (as appropriate) for categorical variables. , statistically significant results.

Back to the Article